OUP Management Co., LLC
- SEC CIK
- 0001880124
- Latest filing
- Nov 9, 2023
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 3, 2022. Long positions only.
- Positions
- 16
- No filing for Q3 2021
- Portfolio value
- $221.9M
- No filing for Q3 2021
OUP Management Co., LLC did not file a 13F for Q3 2021, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| IONQIonQ, Inc. | COM | 4,147,081 | $69.3M | 31.2% | – | – | History |
| CYTCyteir Therapeutics, Inc. | COM | 2,474,572 | $28.1M | 12.7% | – | – | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,341,891 | $26.4M | 11.9% | – | – | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 989,232 | $22.9M | 10.3% | – | – | History |
| DICEDICE Therapeutics, Inc. | COM | 536,693 | $13.6M | 6.1% | – | – | History |
| LABPLandos Biopharma, Inc. | COM | 1,827,478 | $8.77M | 4.0% | – | – | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 1,025,697 | $8.49M | 3.8% | – | – | History |
| DTILPrecision Biosciences Inc | COM | 1,123,913 | $8.32M | 3.7% | – | – | History |
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 1,820,866 | $8.12M | 3.7% | – | – | History |
| JBIOJade Biosciences, Inc. | COM | 603,762 | $7.12M | 3.2% | – | – | History |
| LENZLENZ Therapeutics, Inc. | COM | 406,308 | $5.05M | 2.3% | – | – | History |
| SERASera Prognostics, Inc. | CLASS A COM | 641,361 | $4.41M | 2.0% | – | – | History |
| VORVor Biopharma Inc. | COM | 374,714 | $4.35M | 2.0% | – | – | History |
| SPROSpero Therapeutics, Inc. | COM | 249,070 | $3.99M | 1.8% | – | – | History |
| RNACCartesian Therapeutics, Inc. | COM | 862,543 | $2.81M | 1.3% | – | – | History |
| QTTBQ32 Bio Inc. | COM | 64,000 | $233.0K | 0.1% | – | – | History |